Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Southern-Norway Post-Stroke Atrial Fibrillation Study

NCT07407790 is registered in ClinicalTrials.gov with Sorlandet Hospital HF as lead sponsor.

NCT NCT07407790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07407790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Southern-Norway Post-Stroke Atrial Fibrillation Study
Lead sponsor
Sorlandet Hospital HF
Phase
Not applicable
Overall status
Recruiting
Start date
January 10, 2026
Completion date
December 31, 2029
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia atrial, atrial fibrillation (af), atrial fibrillation (prevention of stroke), ischemic stroke, secondary prevention